Skip to main content
SpringerLink
Log in

Progesterone Receptor, Bcl-2 and Bax Expression in Meningiomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Meningiomas are generally benign central nervous system neoplasms, which frequently express progesterone receptor (PR) and only rarely express the estrogen receptor (ER). For breast cancer, a relation between steroid hormone receptors and proteins involved in the apoptotic process has been described. For meningiomas, the exact relation between PR and these proteins is not known. In this study, ER, PR, bcl-2 and bcl-2-associated × protein (Bax) expression levels were determined in meningioma cytosols. As a reference for our experimental conditions, we also determined these proteins in breast cancer cytosols.

PR and ER were determined with a ligand-binding assay and scatchard-plot analysis. The expression levels of the anti- and pro-apoptotic proteins, bcl-2 and Bax, respectively, were determined by immunoblotting.

In 65% of the meningioma, bcl-2 expression was found in variable amounts. In contrast to breast cancer, a significant negative association between PR and bcl-2 was found (P < 0.01). Bax expression appeared nobreak constitutive, not related to PR, and 2.6 times higher than breast cancer.

As both PR and bcl-2 appear positively associated with prognosis, the negative relationship between bcl-2 and PR found in this study might have some biological and clinical significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smith DA, Cahill DW: The biology of meningiomas. Neurosurg Clin N Am 5: 201-215, 1994

    Google Scholar 

  2. McDermott MW: Current treatment of meningiomas. Curr Opin Neurol 9: 409-413, 1996

    Google Scholar 

  3. Grunberg SM: Role of antiprogestational therapy for meningiomas. Hum Reprod 9(Suppl 1): 202-207, 1994

    Google Scholar 

  4. Blankenstein MA, Blaauw G, Lamberts SW: Progestin and estrogen receptors in human meningioma. Clin Neuropharmacol 7: 363-367, 1984

    Google Scholar 

  5. Blankenstein MA, Koehorst SG, van der Kallen CJ, Jacobs HM, van Spriel AB, Donker GH, van't Verlaat JW, Blaauw G, Thijssen JH: Oestrogen receptor independent expression of progestin receptors in human meningioma-a review. J Steroid Biochem Mol Biol 53: 361-365, 1995

    Google Scholar 

  6. Fewings PE, Battersby RD, Timperley WR: Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence? J Neurosurg 92: 401-405, 2000

    Google Scholar 

  7. Hsu DW, Efird JT, Hedley-Whyte ET: Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86: 113-120, 1997

    Google Scholar 

  8. Zhang GJ, Kimijima I, Tsuchiya A, Abe R: The role of bcl-2 expression in breast carcinomas (Review). Oncol Rep 5: 1211-1216, 1998

    Google Scholar 

  9. Teixeira C, Reed JC, Pratt MA: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902-3907, 1995

    Google Scholar 

  10. Mosnier JF, Perret AG, Brunon J, Boucheron S: Expression of the bcl-2 oncoprotein in meningiomas. Am J Clin Pathol 106: 652-659, 1996

    Google Scholar 

  11. Hara A, Hirose Y, Yoshimi N, Tanaka T, Mori H: Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Neural Res 19: 623-628, 1997

    Google Scholar 

  12. Karamitopoulou E, Perentes E, Tolnay M, Probst A: Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29: 140-145, 1998

    Google Scholar 

  13. EORTC: Revision of the standard for assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1515, 1980

    Google Scholar 

  14. Blankenstein MA, Blaauw G, Lamberts SW, Mulder E: Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols. Eur J Cancer Clin Oncol 19: 365-370, 1983

    Google Scholar 

  15. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976

    Google Scholar 

  16. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications 1979. Biotechnology 24: 145-149, 1992

    Google Scholar 

  17. Koehorst SG, Spapens ME, Van Der Kallen CJ, van 't Verlaat JW, Blaauw G, Thijssen JH, Blankenstein MA: Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins pS2 and cathepsin-D and influence of epidermal growth factor, Forskolin and phorbol ester in vitro. Int J Biol Markers 13: 16-23, 1998

    Google Scholar 

  18. Jacobs HM, van Spriel AB, Koehorst SG, Thijssen JH, Blaauw G, Blankenstein MA: The truncated estrogen receptor alpha variant lacking exon 5 is not involved in progesterone receptor expression in meningiomas. J Steroid Biochem Mol Biol 71: 167-172, 1999

    Google Scholar 

  19. Carroll RS, Zhang J, Black PM: Expression of estrogen receptors alpha and beta in human meningiomas. J Neuro-Oncol 42: 109-116, 1999

    Google Scholar 

  20. Kepes JJ: Meningiomas: Biology, Pathology and Differential Diagnosis. Masson Publishing, USA, NY, 1982

    Google Scholar 

  21. Bickerstaff ER, Small JM, Guest IA: The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychat 21: 89-91, 1958

    Google Scholar 

  22. Markwalder TM, Waelti E, König MP: Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols. Surg Neurol 28: 3-9, 1987

    Google Scholar 

  23. Blankenstein MA, Blaauw G, Croughs RJM: Hormone dependency of meningiomas. The Lancet 17: 1381-1381, 1989

    Google Scholar 

  24. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H: Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33: 212-217, 1993

    Google Scholar 

  25. Maier H, Wanschitz J, Sedivy R, Rossler K, Ofner D, Budka H: Proliferation and DNA fragmentation in meningioma subtypes. Neuropathol Appl Neurobiol 23: 496-506, 1997

    Google Scholar 

  26. Ng HK, Chen L: Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study. Histopathology 33: 64-70, 1998

    Google Scholar 

  27. Patsouris E, Davaki P, Kapranos N, Davaris P, Papageorgiou K: A study of apoptosis in brain tumors by in situ end-labeling method. Clin Neuropathol 15: 337-341, 1996

    Google Scholar 

  28. Kandouz M, Lombet A, Perrot JY, Jacob D, Carvajal S, Kazem A, Rostene W, Therwath A, Gompel A: Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 69: 463-471, 1999

    Google Scholar 

  29. Marone M, Scambia G, Mozzetti S, Ferrandina G, Iacovella S, De Pasqua A, Benedetti-Panici P, Mancuso S: Bcl-2, bax, bcl-xl, bcl-xs expression in normal and neoplastic ovarian tissues. Clin Cancer Res 4: 517-524, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, University Medical Center Utrecht, Utrecht

    F.M. Verheijen, G.H. Donker, C. Sales Viera, M. Sprong, H.M. Jacobs, J.H.H. Thijssen & M.A. Blankenstein

  2. Department of Neurosurgery, De Wever Hospital, Heerlen, The Netherlands

    G. Blaauw

Authors
  1. F.M. Verheijen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G.H. Donker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Sales Viera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Sprong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H.M. Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Blaauw
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J.H.H. Thijssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M.A. Blankenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verheijen, F., Donker, G., Viera, C.S. et al. Progesterone Receptor, Bcl-2 and Bax Expression in Meningiomas. J Neurooncol 56, 35–41 (2002). https://doi.org/10.1023/A:1014404918118

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014404918118

Search

Navigation